HOME
Harmonising Outcome Measures for Eczema
The University of Nottingham
  

Progress

 The task of agreeing core outcomes for eczema trials began in 2008 with a Delphi exercise, and this was followed by a series of consensus meetings. Click on the links below for more details of each stage. 

  • 2008: a web-based Delphi exercise to identify a preliminary core set of outcome domains for clinical trials and clinical record keeping.
  • 2010: an initial meeting (HOME I) in Munich, 2010 to determine if there was sufficient interest to set up a formal HOME group. 
  • 2011: HOME II in Amsterdam, 2011 to agree the domains for inclusion in the core set as clinical signs, patient reported symptoms, quality of life and long term control.
  • 2013: HOME III in San Diego USA, 2013 where consensus was reached that the EASI would be recommended as the core outcome instrument for measuring the clinical signs of eczema.
  • 2015: HOME IV in Malmö, Sweden, 2015 where consensus was reached on POEM as the core outcome instrument for measuring patient-reported symptoms in eczema trials and progress was made on moving towards consensus on quality of life.

 

 

HOME - Harmonising Outcome Measures for Eczema

Centre of Evidence Based Dermatology
University of Nottingham
King's Meadow Campus
Lenton Lane, Nottingham
NG7 2NR, UK

Telephone: +44 115 8232435
Fax: +44 115 8468618
Email: HOME@nottingham.ac.uk